The Latest Cardiac and Vascular News
Ticker to remain NSPR TEL AVIV, Israel, May 10, 2021 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced the Company’s shares have been approved for listing […]
SANTA CLARA, Calif., May 10, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months ended March 31, 2021. Recent Highlights Recognized revenue of $31.9 million […]
Roxadustat net product revenue in China of $15.4 million, on a US GAAP basis Total roxadustat net sales in China of $43.5 million1 by FibroGen and the distribution entity jointly owned by FibroGen and AstraZeneca, compared to $29.2 million last quarter FDA to hold Advisory Committee Meeting on Roxadustat NDA – […]
Toloue brings deep expertise and industry acumen to lead the Company’s strategic expansion into diagnostics BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company helping to transform healthcare with digital protein biomarker technology enabling precision health, today announced it has named Masoud Toloue to the position of President of Quanterix and Diagnostics, […]
ST. LOUIS, May 10, 2021 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the first quarter ended March 31, 2021. “The highlight of the first quarter is Stereotaxis’ return to robust double digit revenue growth with […]
– Enrollment continues in second cohort of EnACT study of MAT2203 (oral amphotericin b) in cryptococcal meningitis; Data and Safety Monitoring Board (DSMB) evaluation of safety and efficacy data from second cohort anticipated Q3 2021 – – MAT2501 (oral amikacin) advanced into preclinical toxicology and efficacy studies; completion of Phase […]
NEW YORK–(BUSINESS WIRE)–Heartbeat Health, a healthcare company working to deliver the most effective, efficient, and engaging heart care, announced today that it has raised $20 million in Series B funding, led by Echo Health Ventures, with participation from DaVita Venture Group and existing investors, .406 Ventures, Optum Ventures, Kindred Ventures, […]
Industry Veterans Join Executive Leadership Team to Empower Next Stage of Company Growth BOSTON–(BUSINESS WIRE)–Elucid, a medical technology company developing AI software to enable cardiovascular disease detection, today announced $8 Million in Series A financing led by MedTex Ventures and Global Health Impact Fund. New and existing investors Checkmate Capital, […]
Conference Call Scheduled for Today, May 6, 2021, at 3:30 PM CT (4:30 PM ET) Revenues of $63.3 million increased 3.4% compared to third quarter last year Net loss of $6.0 million includes $3.4 million related to acquisition of peripheral support catheters from WavePoint Medical, LLC Management provides fiscal 2021 […]
SAN FRANCISCO, May 06, 2021 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended March 31, 2021. First Quarter 2021 Financial Highlights Revenue was $74.3 million, a 17% […]
